BASF SE (XETR:BAS) raised its FY2026 EBITDA outlook while keeping free cash flow guidance steady, even as legal, operational and market risks mount: Syngenta sued over Ridivex, a Ludwigshafen nitrification issue raised Rhine ammonium levels, and JP Morgan warns of margin pressure from supply shifts.
Previous Week Recap
- BASF Raises 2026 EBITDA Guidance: BASF SE raised its FY2026 EBITDA-before-special-items forecast to €6.9–€7.7 billion and kept free cash flow guidance at €1.5–€2.3 billion for 2026.
- Syngenta Sues BASF Over Patent: Syngenta sued BASF (BAS) in Delaware for allegedly infringing a Storen herbicide patent with BASF’s Ridivex, seeking an injunction to block its U.S. launch ahead of key distributor buying season.
- BASF Rhine Effluent Nitrification Rise: BASF SE (BAS): Ludwigshafen plant has reduced nitrification since July 9, raising ammonium levels in Rhine effluent. Company says levels aren’t a human health risk and regulators were notified.
- JP Morgan: BASF Margin Pressure Risk: JP Morgan says BASF faces margin pressure from potential oversupply as Asian producers shift sourcing; Middle East conflict and feedstock uncertainty keep risk high. BASF shares at €48.49, up 0.2%.
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original sources.